Article info
PDFOriginal article
Cost-effectiveness of methoxy polyethylene glycol-epoetin β versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
- Correspondence to Laura Lorente Fernández, Unidad de atención farmacéutica a pacientes externos, Servicio de farmacia, Hospital Universitario y Politécnico La Fe, Edificio C, planta baja, Bulevar Sur, Valencia s/n. 46026, Spain; lorente_lau{at}gva.es
Citation
Cost-effectiveness of methoxy polyethylene glycol-epoetin β versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Publication history
- Received November 29, 2013
- Revised July 29, 2014
- Accepted July 31, 2014
- First published August 21, 2014.
Online issue publication
May 13, 2016
Article Versions
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions